Youths living with type 1 diabetes are more likely to achieve better blood sugar management by using advanced hybrid closed-loop systems, latest research has demonstrated.
During the study, a team of scientists looked at the health outcomes of 42 young people with type 1 diabetes.
Participants were randomly assigned either treatment as usual or advanced hybrid closed-loop therapy.
At the end of the study, the mean HbA1c in those receiving advanced hybrid closed-loop therapy was 8.8 per cent, or 73 mmol/mol, the study has revealed.
Meanwhile, those on continuous subcutaneous insulin infusion (CSII) and using a continuous glucose monitoring (CGM) system had a mean HbA1c of 9.9 per cent, or 85 (13.1) mmol/mol.
Advanced hybrid closed-loop therapy increased time in range 70–180 mg/dL, reduced time >180 mg/dL, with no increase in time spent <70 mg/dL, according to the findings.
However, there was no evidence for differences in psychosocial outcomes between the two groups at study end.
Validated questionnaires were used to assess psychological measures, such as youth-reported problem areas in diabetes, quality of life, anxiety, depression, and hypoglycaemia fear.
“Psychological support remains vital, as technology alone may not be able to reduce the burden of diabetes care in this subgroup,” said the authors.
The research is now available online.
Photo by Tima Miroshnichenko from Pexels
Customer Reviews
Thanks for submitting your comment!